CCL17 and breast cancer: In BC lymphocyte recruitment, CCL17/CCL22 acts as a ligand for CCR4, and CCL17/CCL22 is closely associated with Foxp3+ tumor-infiltrating regulatory T cells (Ti-Tregs) [220].